Sebum excretion rate in subjects treated with oral all-trans-retinoic acid

Dermatology

Volumn 193, Issue 2, 1996, Pages 127-130

  Hommel, L ^a   Geiger, J M ^b   Harms, M ^a   Saurat, J H ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b Intl Center of Clinical Research   (France)

Author keywords

13 cis Retinoic acid; 9 cis Retinoic acid; Acne; All trans retinoic acid; Oral; Sebum excretion

Indexed keywords

CELL NUCLEUS RECEPTOR; RETINOIC ACID;

ABDOMINAL PAIN; ACNE; ADULT; ARTICLE; CHEILITIS; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRY SKIN; HEADACHE; HUMAN; HUMAN EXPERIMENT; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEBUM SECRETION; SIDE EFFECT; VOMITING;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADULT; DRUG ERUPTIONS; FACIAL DERMATOSES; HEADACHE; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; LIP DISEASES; MALE; MUCOUS MEMBRANE; RETINOIDS; SEBUM; SKIN; TRETINOIN;

EID: 0029797665     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246227     Document Type: Article

References (13)

1. Peck G, Olsen T, Yoder F, et al: Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med 1979:300: 329-333.
2. Jones H. Blanc D. Cunliffe J: 13-cis Retinoic acid and acne. Lancet I980:ii: 1048-1049.
3. Farrell L, Strauss J, Stranieri A: The treatment of severe cystic acne with 13-cis-retinoic acid: Evaluation of sebum production and the clinical response in a multiple-dose trial. 1 Am Acad Dermatol 1980;3:602-611.
4. King K. Jones D, Daltrey D. Cunliffe W: A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. BrJ Dermatol 1982:107: 583-590.
5. Doran T, Shapiro S: Retinoids effects on sebo-cyte proliferation; in Parcker L (ed): Methods in Enzymology. San Diego. Academic Pess. 1990. pp 334-338.
6. Doran T. Shapiro S. McLane J, et al: Activity and metabolism of 9-cis retinoic acid in models of dermatology; in Livrea M. Vidali G (eds): Retinoids: From Basic Science to Clinical Applications. Basel. Birkhâuser, 1994. pp 315-328.
7. Geiger J-M, Hommel L, Harms M, Saurai J-ll: Oral 13-cis retinoic acid superior to 9-cis retinoic acid in sebosuppression in human beings. J Am Acad Dermatol 1996;34:513-515.
8. Cunliffe W, Kearney J, Simpson N: A modified photometric technique measuring sebum excretion rate. J Invest Dermatol 1980:75: 394-398.
9. Saint-Léger D, Berrebi C, Du box C, Agache P: The Lipomètre: An easy tool for rapid quantification of skin surface lipids (SSL) in man. Arch Dermatol Res 1979:265:79-89.
10. Geiger J-M: Retinoids and sebaceous gland activity. Dermatology 1995:191:305-310.
11. Plcwig G. Schill W. Hofmann C: Orale Behandlung mit Tretinoin: Andrologische, tri-chologische. ophthalmologische Befunde und Therapieergebnisse bei Acne. Arch Dermatol Res 1979:265:37-47.
12. Allcnby PNAS. Allcnby G. Bocqucl MT. Sanders M. Kazmer S. Speck J. Rosenberger M. Lovey A, Kästner P. Grippo JF. Chambon P: Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acid. Proc Natl Acad Sei USA 1993;90:30-34.
13. Sass JO, Masgrau E. Saurat JH. Nau H: Metabolism of oral 9-cis retinoic acid in the human: Identification of 9-cis retinoyl-ß-glucuronide and 9-cis-oxo-retinoyl-ß-glucuronide as urinary metabolites. Drug MetabDispos 1995:23: 887-891.